Drugs / Lortab
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | LORTAB | — | 1982-07-09 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01668849 Comparator | Aug 2012 → May 2022 | chemotherapy-induced oral mucositis, head and neck cancer | University of Louisville | Completed | No outcome recorded |
| — | NCT01708473 Comparator | Jul 2011 → Feb 2012 | cutis laxa | Ulthera, Inc | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lortab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01708473 ↗ |